Isatin

吲哚醌

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameIsatin
Drug Alias NameMW-147ISA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitors
TargetsMonoamine oxidase B
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (IND)
Highest Status in ChinaPending
Originator CompaniesShanghai Xinshengyuan Biological Medicine Co LtdMerck SeronoWuhan Kangliyuan Pharmaceutical Technology Co Ltd +[4] 
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesN/A
Inactive CompaniesQingdao UniversityWuhan Kangliyuan Pharmaceutical Technology Co LtdWuhan Optics Valley New Medicine Incubation Public Service Platform Co Ltd
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A